MICB and neoplasm: Alternatively, tumour immune evasion mechanism involves internalization and shedding of NKG2Dligands’, MHC class I chain-related proteins A and B (MIC-A and MIC-B) and UL16-binding proteins (ULBPs), ensuing inhibition of NK cell-mediated cytotoxicity4,5.